|
HS Code |
464987 |
| name | Pentaquine |
| chemical_name | 8-(4-diethylamino-1-methylbutylamino)-6-methoxyquinoline |
| drug_class | Antimalarial |
| molecular_formula | C19H28N4O |
| molecular_weight | 328.45 g/mol |
| route_of_administration | Oral |
| mechanism_of_action | Disrupts parasite metabolism in erythrocytic and exoerythrocytic stages |
| primary_use | Treatment and prevention of malaria |
| ATC_code | P01BA02 |
| status | Obsolete; replaced by safer alternatives |
| side_effects | Hemolytic anemia, especially in G6PD-deficient patients |
As an accredited Pentaquine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Pentaquine packaging features a white, labeled cardboard box containing 100 mg tablets, each blister pack includes 10 tablets for pharmaceutical use. |
| Shipping | Pentaquine should be shipped in tightly sealed containers, protected from light and moisture. It must be labeled appropriately as a pharmaceutical chemical, complying with local regulations. During transport, maintain ambient temperature and prevent exposure to extreme conditions. Ensure it is handled by authorized personnel and accompanied by safety documentation, including Safety Data Sheets (SDS). |
| Storage | Pentaquine should be stored in a tightly closed container, protected from light and moisture. It should be kept in a cool, dry place, ideally at a temperature between 15°C and 30°C (59°F to 86°F). Ensure the storage area is well-ventilated and away from incompatible substances. Keep out of reach of unauthorized personnel and children. |
Applications of Pentaquine in Industrial ManufacturingAs a leading direct manufacturer, we supply Pentaquine to established downstream sectors requiring high standards of purity, regulatory compliance, and consistent performance. The following application fields reflect current industry use, controlled integration parameters, and validated production workflows. 1. Pharmaceutical Antimalarial Drug FormulationPharmaceutical companies formulate Pentaquine as an active pharmaceutical ingredient in antimalarial combination therapies targeting Plasmodium vivax elimination. Formulators must address precise dosage calculation, compounding with compatible excipients, and stringent in-process controls. Batch records demand traceability and in-depth stability studies to support registration dossiers for regulatory submissions. Finished preparations require uniform drug dispersion achieved by optimized blending under Class D/GMP conditions, and humidity and light controls throughout granulation and tableting stages. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Veterinary Protozoal Treatment FormulationLeading veterinary medicine producers deploy Pentaquine in coccidiosis and hemoprotozoan treatment blends for livestock and companion animals. Product forms often target water-soluble powders or medicated premixes to enable efficient farm-level administration. Strict withdrawal period calculations support food safety, requiring compliance with defined residue limits. Manufacturers must validate uniformity within carrier matrices and account for inter-species dose variation based on established pharmacological data. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Reference Standard Supply for Analytical TestingGlobal pharmaceutical quality control laboratories, contract research organizations, and hospital research centers utilize high-purity Pentaquine as a reference material in quantitative and qualitative assay development. Accurate calibration ensures reliable results for batch release, stability analysis, and method validation studies required by regulatory filings. The material must meet strict analysis validation markers, including high chromatographic purity, consistent assay content, and tightly controlled residual solvent levels. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Synthesis of Specialty Intermediates for Bulk Chemical SectorsBulk chemical and fine chemical industries source Pentaquine for controlled transformation into specialty intermediates used in advanced material or pharmaceutical intermediate synthesis. The process requires detailed kinetic studies to optimize reaction time and yield, avoid over-oxidation, and maintain side-product control. Manufacturers must document origin, batch traceability, and impurity profiles to meet downstream traceability requirements imposed by high-value end users. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Pentaquine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Daily work in our facility means we get to know our products from the ground up. One example is Pentaquine. For more than ten years, our batch operators, process engineers, and quality control specialists have handled the process from raw materials to finished goods. This gives us a unique perspective that’s difficult for marketers, traders, or resellers to match. The feedback we hear from coating specialists, pharmaceutical chemists, and QC labs ends up shaping our approach to this active ingredient. Our facility has been updated to match the increased demand for Pentaquine, especially for manufacturing applications where production reliability and lot consistency make all the difference.
You will most often see Pentaquine offered as a crystalline powder, ranging from off-white to pale yellow. The process begins with a careful combination of intermediate chemicals, guided by in-line spectrometry and strict batch monitoring in our control rooms. We target a high degree of purity, typically over 99.4 percent on a dry basis, with moisture content under 0.2 percent, as measured by Karl Fischer titration. Our facility supports both general laboratory-grade and advanced pharmaceutical-grade Pentaquine. You won’t see fillers or unwanted side products, because our process includes column chromatography and several filtration steps that pull out even the smallest impurities—removing carry-overs is non-negotiable for our chemists.
The typical lot rolls out in 1-kilogram to 100-kilogram drums, double-lined for both moisture protection and contamination avoidance. Using dedicated production lines keeps cross-contamination virtually nonexistent, not just for regulatory compliance but for customer trust. For customers who rely on automated feeders, we adjust particle size distribution by modifying our recrystallization step—steeper cooling rates and filtered agitation bring finer control, which means better flow and handling in end-use manufactories.
Most of the Pentaquine produced here winds up in pharmaceutical applications. It appears in antimalarial formulations—usually as a mainstay where resistance patterns have narrowed down options for practitioners. Medical researchers come to us for larger pilot batches during clinical trial preparation, appreciating the reliable lot-to-lot consistency and thorough documentation. In finished drugs, the exacting needs of regulatory audits and validation work mean suppliers must stand behind every kilogram shipped.
At the same time, some industrial clients use Pentaquine as a reference material in trace detection and quality control studies. Analytical chemists tell us that our Pentaquine helps them calibrate equipment for mass spectrometry and HPLC, thanks to well-documented purity, melting point, and spectral fingerprint. Over the years, we have improved tracking and validated every step from weighing raw ingredients to sealing every drum, giving downstream users a stronger paper trail. Chemical manufacturers like us invest in extra lot validation, not out of routine, but to protect end users and climb above the baseline level of market supply.
After years in the industry, we get regular calls from customers who tried other sources and ran into trouble with questionable purity, clumping, or inconsistencies in performance data. Some tell us about receiving materials with a musty odor, odd coloration, or failing standard analytical tests. Often, these problems could stem from imprecise syntheses or lack of batch segregation.
With our in-house research and production teams, we have learned the value of close monitoring to keep crystalline form, particle size, and chemical integrity in check. Others pursue only yield and neglect repeatability; our process doesn’t cut corners at purification or documentation. By investing in regularly upgraded analytical instruments—HPLC, GC-MS, polarimetry—we establish a product profile that matches users' expectations from pharma to academic labs. This commitment does not just serve compliance but builds relationships, as customers who test side-by-side see clear differences in solubility, reactivity, and absence of off-spec contaminants.
After testing, pharmaceutical teams often notice how our Pentaquine dissolves predictably in solvents, allowing for a smoother QA/QC process. Even small differences in moisture or particle size can introduce variability in lab results. Our direct manufacturing approach means we offer technical support rooted in daily experience, not out of a manual but from time spent on the production floor. Keeping detailed records helps us troubleshoot any rare issues quickly—our chemists pull samples from retained batches and can provide spectral data, origin details, and process notes within hours of a request.
About a decade ago, we produced Pentaquine under strictly manual conditions, relying heavily on operator intuition and basic equipment. The challenge then was keeping every batch within narrow purity specs while scaling for increased output. When production volumes began to accelerate, our team initiated automation for key synthesis reactions and real-time monitoring for critical steps. Small upgrades, like closed-system transfer for reagents or inline temperature controls, reduced risk of contamination and batch variance.
We even adjusted supply chain logistics, storing raw intermediates under nitrogen and refining cleaning standards between runs. Some of these measures require substantial up-front cost, but feedback from end-users who flagged oddities in previous batches proved every improvement worthwhile. Knowing a shipment can be traced back to its raw reagents, reaction conditions, and every line operator keeps accountability high and trust intact.
Today, with digital documentation and scheduled cross-checks, batches clear both our in-house and third-party quality reviews. This multi-layered scrutiny means that if a customer—perhaps a pharmaceutical formulator or government auditing body—requests data from any production stage, we can provide a thorough history, including chromatograms, NMR spectra, and precise timestamps.
Producing chemicals like Pentaquine offers its share of hurdles. Sourcing high-quality starting materials sometimes forces us to look across multiple markets and check dozens of supplier backgrounds. Fluctuations in precursor availability or purity can stress the production schedule. On occasion, we push deadlines and work late to troubleshoot an unexpected shift in a reaction profile or an off-spec impurity detected at the final QA step.
We respond by working in smaller, tightly-controlled batches while verifying each raw input. Operators communicate quickly if a batch appears out of the ordinary, and production only resumes once analytical results come back clean. Over time, we have established contingency plans for delayed shipments or supply chain disruptions, including holding buffer raw material reserves and keeping backup purification media on site.
Shipping also brings challenges, particularly with seasonality, humidity swings, and the need for compliant export documentation. By managing our own fulfillment, rather than outsourcing logistics, we reduce risk of transit damage, customs issues, and delays. Customers in distant markets often remark on the improved state of material they receive compared to less carefully handled shipments from other producers. These small operational details have a direct impact on product reliability, and customers see the difference in both the product and service follow-up.
Some of our best practices originated from customer feedback. A pharmaceutical QA manager once sent us comparative dissolution test data, showing our Pentaquine outperforming two competitors’ samples in a finished dosage form. The difference stemmed from particle size and moisture binding; after consulting, we adjusted filtration and drying parameters. Another research group flagged a subtle pH drift in long-term stability, which prompted us to experiment with inert-atmosphere packaging and more stringent end-point testing. Real insights come from field use, not textbook knowledge.
We consider every informed complaint as data. Our technical service team, composed of chemists who have rotated through actual production shifts, translates these insights rapidly into manufacturing adjustments. Simple suggestions, such as improved drum labeling or easier access to certificates of analysis and safety datasheets, have been incorporated into our routine. This hands-on approach encourages long-term relationships built on accountability—not just meeting but exceeding stated specifications.
With regulatory standards tightening globally, sourcing genuine, traceable active ingredients like Pentaquine grows more important each year. Off-brand, unverified raw materials not only threaten compliance but can disrupt full-scale manufacturing projects. We have seen projects stall because of poorly documented Pentaquine, causing financial losses and missed market opportunities for drug makers.
Our transparent manufacturing operations answer these concerns by proving lot origin, process history, and finished goods data with every shipment. Auditors typically demand complete traceability, which we document during every production step. Laboratory analysts rely on robust reference data, not just once but batch after batch. We see the broader implications—one faulty shipment can jeopardize entire clinical campaigns or trigger regulatory warnings. Our customers’ peace of mind rests on our willingness to supply not just product but also process evidence and post-shipment support.
Developments in parasite resistance and public health priorities keep Pentaquine in demand. Some countries experience periodic shortages when stocks run low or when supply chain interruptions—shipping restrictions, raw material scarcities—arise. Our ability to produce at scale, from kilogram prototypes to multi-ton lots, helps drug firms, government buyers, and NGOs avoid gaps. Feedback we gather from doctors and medical deployment teams helps us respond faster to shifts in usage patterns and emerging needs.
Unlike commodity chemicals, specialty APIs such as Pentaquine depend on detailed oversight of both synthesis and documentation. Decisions made at the reactor or quality bench ripple outward, influencing drug approval and patient outcomes. As manufacturers, we consider ourselves custodians of safety, not simply suppliers. Every investment in tighter filtration, upgraded analytical labs, or redundant documentation brings a return in fewer errors and higher trust—from major drug companies to small research teams.
Traders and distributors can recite general selling points, but deep answers about solubility profiles, particle behaviors, or impurity origins come from years of direct handling. Our operators know what a correct batch of Pentaquine smells like, how it pours, and what a typical chromatogram reveals about hidden isomers. This day-to-day exposure enables fast, informed troubleshooting and fosters a sense of pride inside the facility.
After implementing changes inspired by customer field use—tighter particle cuts, improved packaging, and real-time shipping updates—we noticed a drop in complaint rates and an increase in returning customers. Unlike generic factory output, our product reflects hundreds of incremental improvements based on measurable customer outcomes. The technical details, the production tweaks, and the supply chain fixes only make sense to those who see the whole process repeatedly, not just through paperwork but in real pressures and production challenges.
Market comparisons sometimes show cheaper options with generic origins. Some customers save a few percent but end up spending more correcting batch failures or retesting questionable samples. Real cost emerges through downtime, product requalification, and extra analytical effort. Our batches are documented so deviations in particle size, odor, color, impurity level, or residual solvent content are highly unlikely—these variances show up in side-by-side testing, and lab results speak for themselves.
Partners who demand tight turnaround, validated documentation, or technical support after shipment soon recognize the value of working with a manufacturer. A distributor buys and resells what they receive; we control every step and answer for every drum. When field chemists or QA teams call needing a deeper answer, only someone with hands-on production knowledge can respond with usable guidance—and provide immediate cross-checks if issues arise. We send not just goods, but a complete background, and, for returning partners, process improvement advice that can help on their end as well.
Compliance-driven industries like pharmaceuticals cannot accept unknowns in critical raw materials. Regulatory reviews drill into every supply chain detail, scrutinizing impurity levels, solvent residues, and batch references. In our experience, Lot traceability and documentation make the difference between smooth audit clearance and costly delay.
To stay ahead, we invest frequently in GMP alignment, third-party process validation, and regular internal audits. Every shipment includes complete batch certificates, spectral documentation, and MSDS access—no request for documentation goes unfulfilled. Our delivery records reach back over a decade, and improvements are ongoing as regulatory needs evolve. Drug manufacturers and research groups usually return for repeat orders, knowing they won’t face last-minute surprises or hidden compliance lapses.
The landscape for Pentaquine will keep changing as regulations, clinical needs, and international standards develop. For drug development programs or mass treatment initiatives to succeed, API reliability becomes central to project success. Our history includes scaling up production in response to both long-term market demand and urgent humanitarian calls. By working directly with customers at every manufacturing and support stage, we keep quality high and ensure the chain from synthesis to delivered shipment remains intact.
Future improvements—upgraded reactor systems, even tighter analytics, and smarter shipping alerts—stem from constant review and relentless feedback from real-world applications. Upgrading isn’t a one-time fix but a steady progression. Every change hinges on data and customer experience, not theory or market speculation. We approach Pentaquine production with respect for its purpose—protecting patient health and supporting laboratory innovation. This means managing every minute detail, from sourcing raw material to the last signature on a shipping manifest, with the deepest accountability.